The unfulfilled promise of biotechnology firms: a top management team-based explanation
Hakan Ener
Industrial and Corporate Change, 2017, vol. 26, issue 5, 887-906
Abstract:
A key feature of biotechnology firms’ business models is the tendency to branch into related therapeutic markets within the same industry in developing new products. Recent analyses revealed that this business model has not paid off for the vast majority of firms in this industry. Building on theories of learning and attention, and supported by empirical analyses of firms’ ability to develop new products over two decades, this article finds evidence that initiating new product development projects targeting new-to-the-firm therapeutic markets within the same industry disrupts firms’ product development projects in their existing markets. This effect is primarily driven by firms that ventured into therapeutic markets that were not highly related to their area of expertise, and firms that did not recruit top executives with experience in newly entered markets. These results help to explain the poor performance of biotechnology firms in getting new products to market.
JEL-codes: L25 L65 M13 (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:
Downloads: (external link)
http://hdl.handle.net/10.1093/icc/dtw054 (application/pdf)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:oup:indcch:v:26:y:2017:i:5:p:887-906.
Ordering information: This journal article can be ordered from
https://academic.oup.com/journals
Access Statistics for this article
Industrial and Corporate Change is currently edited by Josef Chytry
More articles in Industrial and Corporate Change from Oxford University Press and the Associazione ICC Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK.
Bibliographic data for series maintained by Oxford University Press ().